These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29103516)
21. Self-assembled polymeric nanoparticle of PEGylated chitosan-ceramide conjugate for systemic delivery of paclitaxel. Battogtokh G; Ko YT J Drug Target; 2014 Nov; 22(9):813-21. PubMed ID: 24964055 [TBL] [Abstract][Full Text] [Related]
22. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel. He R; Yin C Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W; Cheng L; Li B Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039 [TBL] [Abstract][Full Text] [Related]
26. Development of a thermally responsive nanogel based on chitosan-poly(N-isopropylacrylamide-co-acrylamide) for paclitaxel delivery. Wang Y; Xu H; Wang J; Ge L; Zhu J J Pharm Sci; 2014 Jul; 103(7):2012-2021. PubMed ID: 24823900 [TBL] [Abstract][Full Text] [Related]
28. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
29. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route. Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite. Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139 [TBL] [Abstract][Full Text] [Related]
31. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M; Shrivastav TG; Kharbanda S; Singh H ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585 [TBL] [Abstract][Full Text] [Related]
32. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation. Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688 [TBL] [Abstract][Full Text] [Related]
33. Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel. Di Mauro PP; Borrós S Pharm Res; 2014 Dec; 31(12):3461-77. PubMed ID: 24939639 [TBL] [Abstract][Full Text] [Related]
34. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model. Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913 [TBL] [Abstract][Full Text] [Related]
35. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma. Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632 [TBL] [Abstract][Full Text] [Related]
36. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
37. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
38. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma. Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068 [TBL] [Abstract][Full Text] [Related]
39. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics. Ashrafizadeh M; Ahmadi Z; Mohamadi N; Zarrabi A; Abasi S; Dehghannoudeh G; Tamaddondoust RN; Khanbabaei H; Mohammadinejad R; Thakur VK Int J Biol Macromol; 2020 Feb; 145():282-300. PubMed ID: 31870872 [TBL] [Abstract][Full Text] [Related]
40. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy. Liang Y; Dong C; Zhang J; Deng L; Dong A Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]